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INTRODUCTION TO PROTEOMICS
Proteomics is the study of the protein complement or proteome, done through mass spectrometry (MS) (1-8).
Proteomics focuses on analysis of proteins and protein derivatives (i.e., glycoproteins), peptides, protein-protein interactions (PPIs) or post-translational modifi cations (PTMs) within proteins. A proteomics experiment starts with sample fractionation prior to analysis by MS (9) , which involves one or more biochemical separation methods such as electrophoresis (SDS-PAGE, 2D-PAGE), centrifugation or chromatography (affi nity purifi cation). In some cases, fractionation can also be bypassed, provided the instrumentation used can handle complex protein samples (i.e., cell lysates). However, in most cases, fractionation is followed by further separation methods such as additional chromatography (i.e., size exclusion chromatography) or centrifugation (i.e., centrifugation-based affi nity chromatography columns). If the protein sample is not very complex, fractionation is directly followed by enzymatic digestion (i.e., trypsin) and peptide extraction. Th e peptide mixture is then further fractionated by HPLC or UPLC and then analyzed by MS (1). Data analysis usually leads to identifi cation of one or more proteins. Th is is the end goal in most proteomics experiments, but in some cases this is just a start. Additional investigation of the MS data can extract information that leads to identifi cation of potential interaction partners of some proteins (protein-protein interactions), or of modifi cations of that protein (natural or unnatural PTMs (8, (10) (11) (12) . A schematic workfl ow of a proteomics experiment is shown in Fig. 1 .
PROTEIN IDENTIFICATION AND CHARACTERIZATION: IDENTIFICATION OF POST-TRANSLATIONAL MODIFICATIONS (PTMS)
MS-based identifi cation of one peptide that contains the amino acid sequence specifi c to a protein is usually enough for identifi cation of that protein. Once the protein is identifi ed, then it is characterized. However, identifi cation of two peptides that are part of the same protein is better and, as a general rule, the more peptides are identifi ed per protein, the higher the probability (and confi dence) that the protein identifi ed is the correct one. Assuming that a 50 kDa protein can in theory produce at least 50 peptides, identifying a protein based on only one or two peptides seems easy. Th is is true, up to a point: good MS instrumentation, low fl ow rate of the HPLC/UPLC, good software for data analysis, good technical expertise for protein digestion and peptide extraction, etc. However, when it comes to protein characterization, a great challenge is encountered by most biochemists, protein chemists and mass spectrometrists. In addition, to succeed in protein identifi cation and characterization, a combination of bottom-up and top-down proteomics should be used (13, 14) .
TOP-DOWN MS AND PTM ANALYSIS
A top down approach allows for the identifi cation of protein isoforms and/or any potential post-translational modifi cations within these proteins (15) . Once the protein's identity is known, the protein characterization using MS is usually completed through an interconnected, two-step approach: 1) a top-down MS approach where intact proteins are investigated and their molecular mass is determined and 2) a bottom-up approach where proteins are digested and the peptides mixture is analyzed, as described in Fig. 1 . While the bottom up approach is experimentally similar to top-down approach for both 1) protein identifi cation based on minimum one peptide and 2) full characterization of a protein, the diff erences between these two approaches are rather great and will be listed below.
Top down MS can be used to investigate the molecular mass of the protein of interest, usually the fi rst step in its characterization. While the mass of a protein can be determined with various native (i.e., size exclusion chromatography) or non-native, denaturing (electrophoresis/SDS-PAGE) biochemical methods, the error produced by these methods is rather large (up to 10% of the mass of the protein). Th erefore, these methods for determination of a protein's molecular mass are merely a gross estimation, far from their exact or nearly-exact mass. As such, the only accurate method used for determination of a protein's mass and then amino acid sequence information is by top down MS (using a MS with either a MALDI or ESI source followed by MS/MS). Determination of the mass of a protein is important in cases like investigating the modifi cations and degradations to which hormones are subjected when they are released under natural and close-to-natural "sense and release" conditions. In one of our recent publications, we investigated whether insulin released electrochemically is 1) indeed released and 2) not modifi ed or degraded (in a system that can sense high concentrations of glucose, then releases insulin to reduce the glucose levels) (16) . While the insulin release could easily be detected by other methods (i.e., insulin labeled with a fl uorophore), any potential modifi cations of insulin (i.e., oxidations) and degradations could only be demonstrated by MS. An example of such an experiment is shown in Fig. 2 .
Another example where determination of the molecular mass of a protein by top-down proteomics is important is in identifi cation and characterization of antibodies that . Th e (6+) peak of insulin is also shown. Again, no major degradation products of insulin were observed. Reprinted and adapted with permission from (16).
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are used as either therapeutics/immuno therapeutics or as drug carriers (antibody-drug conjugates). Analysis of the antibody in the non-reducing conditions (disulfi delinked), then reducing conditions (individual light and heavy chains) and then de-glycosylated heavy chains (treated with peptide-N-glycosidase F (PNGaseF), which removes N-linked oligosaccharides from the NXS/T glycosylation sites) allows simultaneous identifi cation of the diff erences between the glycosylated and non-glycosylated heavy chain as well as comparison with the theoretical molecular mass (30) . Th is also leads to identifi cation of potential mutations or modifi cations of both heavy and light chains. Top down proteomics also allows for identifi cation of the potential natural and artifi cial modifi cations. Furthermore, simple MS analysis of the intact proteins allows for identifi cation of the type and number of these modifi cations. One such example is 4-hydroxy-2-nonenal (HNE) modifi cation, shown in Fig. 3 . As observed, MS analysis allows not only the identifi cation of HNE molecules, but also the number of HNE molecules that are covalently bound to lysozyme, a model protein, as well as the type of modifi cation (Michael-based addition or Schiff -base formation) (17) .
BOTTOM UP PROTEOMICS AND PTM ANALYSIS
In a bottom-up approach, after the proteins are fractionated by a biochemical approach, they are digested and subjected to MS analysis by tandem mass spectrometry (MS/MS or ESI-MS/MS) or by peptide mass fi ngerprinting for protein identifi cation (in MALDI-MS analysis). Since bottom up approaches allow for identifi cation of parts of a protein (peptides), their fragmentation by MS/MS also allows for identifi cation of the amino acid sequence of that peptide. Th is leads to identifi cation of the protein that has the identifi ed amino acid sequence. Furthermore, MS/MS analysis of peptides also allows us to identify all potential PTMs on that peptide (and to pinpoint towards the amino acid that is modifi ed), regardless of whether they are natural PTMs or artifi cial, experiment-borne PTMs.
While identifi cation of a protein based on the amino acid sequence of one peptide is relatively straightforward, the challenge comes when the full coverage of that particular protein is required. For example, if a trypsin digestion of a protein will lead to identifi cation of ~20-30% coverage of that particular protein, increase of that coverage can easily be extended to 60-70% by either increasing the amount of protein analyzed, or lowering the fl ow rate of the HPLC/UPLC or increasing the length of the UPLC gradient. However, rarely the protein coverage is higher than 70%, simply because some parts of the protein are hydrophobic or have not enough or too many tryptic cleavage sites (and as consequence, the peptide fragments are either too big or too small for MS analysis). Th erefore, a complementary digestion approach by using a diff erent enzyme, such as chymotrypsin or AspN will be needed. In addition, success in protein identifi cation and characterization is fully dependent on a combination of bottom-up and top-down proteomics (13, 14) . Once the protein is identifi ed and has full/maximum peptide coverage, the PTM analysis can proceed, which is diff erent, depending on the type of PTM (glycosylation, phosphorylation or acetylation), its status (stable or transient) and its origin (natural or experimental PTMs).
COMMON, KNOWN, NATURAL PTMS IN PROTEINS
MS-based characterization of proteins is diffi cult, even more complicated due to the PTMs of proteins (18) . Th is is also dependent on what type of PTM is investigated. Th e stable modifi cations such as glycosylation or disulfi de bridges are relatively easy to detect, but diffi cult to interpret. Other PTMs such as phosphorylation, acetylation or methylation are transient, and also diffi cult to identify. It is even more diffi cult to identify PTMs and give them biological signifi cance, i.e. to pinpoint the role of that PTM in a cell or a tissue.
Two major PTMs in proteins are glycosylation and phosphorylation. Glycosylation is usually found in extracellular proteins and is responsible for protein-glycoprotein or ligand-lectin interaction (19, 20) . In the pharmaceutical and biotechnology industries, glycosylation is an important modifi cation/PTM of recombinant proteins, which has dramatic eff ects on the stability and solubility of those proteins (21, 22) .
Glycoprotein analysis is usually accomplished by LC-MS/MS of the glycopeptides produced by enzymatic (i.e., trypsin) digestion. Glycopeptide analysis allows for identifi cation of hexose diagnostic fragments (23) (24) (25) . However, this method is not very eff ective, because the glycoproteins are not detected very effi ciently (poor signal in MS analysis). Th erefore, affi nity chromatography-based glycoprotein enrichment (i.e., by lectins), chip-based glycoprotein analysis (26, 27) or customized fragmentation methods such as collision induced dissociation (CID) for producing ions mainly of the glycan chain or electron transfer dissociation (ETD) for the specifi c fragmentation of the peptide backbone greatly improves the outcome of the MS analysis of glycoproteins (28, 29) .
A complementary analysis of glycoproteins involves enzymatic digestion of the glycans upon their enzymatic cleavage from the proteins. As such, the glycans can be analyzed in negative mode and the location of the glycan on peptide can be identifi ed by analysis of the peptide that releases the glycan. Negative or negative ionization refers to polarity of the current; usually peptides are analyzed in positive ionization mode while glycans in negative ionization mode. In the simplest example, N-linked glycans are released by enzymatic treatment with peptide-N-glycosidase F (PNGaseF), while O-linked glycans can be released by -elimination. Advantages and disadvantages of using the glycan digestion include among others increase of ionization effi ciency and hydrophobicity of the digested peptide and separate characterization of the glycan and peptide sequence (pros) and potential false positive because of the spontaneous deamidation of asparagine residues and the loss of information regarding site-specifi c characterization of glycan heterogeneity (cons).
PNGaseF treatment leads to identifi cation of the N-linked glycans, in which the asparagine that contains the glycan is converted to aspartate, which leads to a 1 mass unit increase within the peptide (30) . Th is change is more than enough for MS-based identifi cation. Th e PNGaseF treatment can also be performed in presence of H 2 18 O, which allows an easier identifi cation of the glycosylation site (31) . In the case of O-linked glycans, which are linked through an O-glycosidic bond to a serine or threonine residue, their enzymatic removal converts serine to alanine and threonine to aminobutyric acid; in both cases, the outcome is a loss of 16 mass units/Da within the peptide bearing the O-linked glycan (32, 33) .
Glycan analysis can also be used to investigate the N-glycosylation site occupancy. Figure 4A shows an example of a MS/MS analysis where the increase of a peptide molecular mass is due to PNGaseF-based release of glycan and conversion of asparagine to aspartate, suggesting that the peptide is glycosylated. Figure 4B shows an example of a MS/MS analysis where the same asparagine from the same NST glycosylation site, from the same peptide as the one shown in Fig. 4A , is not glycosylated and therefore not converted to aspartate.
Th is data suggests that the NST glycosylation site can be investigated not only for the transition of asparagine to aspartate in NST site due to glycosylation but also of the asparagine site in NST site due to non-glycosylation.
Phosphorylation is a diff erent PTM that is reversible and transient and is important in regulation of many cellular processes (34) . It is well-demonstrated that abnormal protein phosphorylation leads to the onset of various diseases (35, 36) and identifi cation of protein phosphorylation allows understanding of many physiological processes such as the signal transduction pathways, which in turn can help in developing new therapeutic targets (37) (38) (39) .
MS-based identifi cation and characterization of phosphorylation on peptides is usually achieved by 
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scanning for neutral loss of HPO 3 (80 Da for phosphotyrosine) and H 3 PO 4 (98 Da for phosphoserine and phosphothreonine residues), such as neutral loss triggered MS3 or neutral loss electron transfer dissociation/electron capture dissociation (40, 41) . It is worth noting that phosphotyrosine peptides are not very often observed as neutral loss in positive ionization mode (42) , but can easily be observed in negative ionization mode if the peptides are methyl esterifi ed (43) . Th ese experiments usually lead to identifi cation of the phosphopeptides and of the amino acid that is phosphorylated (serine, threonine or tyrosine) (44) (45) (46) . While this approach is straightforward, many times it is not good enough for identifi cation of the full phosphoproteome, simply because the phosphopeptides may not be abundant enough and as such, enrichment of phosphopeptides using TiO 2 , immobilized metal affi nity chromatography (IMAC), or a combination of TiO 2 and IMAC (TiMAC) is needed (47, 48) . Affi nity-based enrichment using antibodies (anti-phospho-serine, anti-phospho-threonine or anti-phospho-tyrosine) can also be (and are) used.
Th e approaches described for analysis of PTMs like phosphorylation or glycosylation at the MS level are not limited to these two PTMs and can be adapted and then applied to other PTMs. For example, methods such as multiple reaction monitoring (MRM) for quantitative analysis of phosphopeptides or customized data-dependent analysis (DDA using an inclusion list, also known as information-dependent analysis or IDA) for N-glycan occupancy analysis, product ion discovery (PID) for glycan analysis (and detection of the hexose or N-acetyl-neuraminic acid product ions) or neutral loss for phosphorylation analysis are commonly used for identifi cation of all kinds of PTMs (8, 12, 17, 30, 49, 50) .
EXPERIMENT-BORNE PTMS IN PROTEINS: THE KNOWNS AND THE UNKNOWNS
During protein digestion, two main experiment-borne procedures modify the proteins: reduction and alkylation of cysteine (acrylamide-or iodoacetamide (IAA)-based alkylation of cysteine residues) and methionine oxidation. Th e modifi cations on these two amino acids can easily be controlled at the bioinformatics level: during database search one will use fi xed modifi cations for acrylamideor IAA-based alkylation of cysteine (propionamide-and carbamidomethyl-cysteine) and variable modifi cation for methionine (methionine oxidation). While controlling modifi cations of these amino acids in proteins is relatively straightforward, controlling of most experiment-borne PTMs on amino acids other than cysteine or methionine is practically impossible. In the simplest example, IAA usually alkylates/should alkylate only cysteine. However, in a previous study, our lab demonstrated that many cysteine-less peptides are still modifi ed by IAA (and many times by more than one molecule of iodoacetamide) (50) . One of the worst consequences for this unexpected modifi cation is not only the inability to identify a modifi ed peptide, but also the infl uence on the quantitative analysis when such peptide is used. An example of such a modifi cation is shown in Fig. 5 , where a cysteine-less peptide has no modifi cations, but it is also modifi ed by one and two molecules of IAA (50) . Interesting to note, when two molecules of IAA (2 x 57 Da) modify a peptide, then IAA-modifi ed peptide artifacts mimic protein ubiquitination, which is a di-glycine (2 x 57 Da) (51) .
A diff erent example where unwanted modifi cations of amino acids in proteins happen, is in oxidative stress, particularly lipid peroxidation and subsequent modifi cation of proteins. Such a phenomenon happens in the retina. In one of our recent studies, we used two model proteins (BSA and lysozyme) to investigate the amino acids that are modifi ed by HNE (17) . Th e amino acids that were expected to be modifi ed were histidine, lysine and cysteine. Our proteomics experiments on our HNE-modifi ed model proteins confi rmed that these amino acids are indeed modifi ed. However, we also demonstrated that many additional amino acids, previously not known to be modifi ed by HNE were unexpectedly modifi ed (17) . Th erefore, our lab showed again that the most dangerous modifi cations are the ones that are unknown and unpredictable. An example of such a modifi cation is shown in Fig. 6 .
FALSE POSITIVES, FALSE NEGATIVES AND GOOD QUALITY SPECTRA WITH NO MATCH
Many MS/MS spectra from a proteomics experiment do not lead to identifi cation of any peptides, simply because the quality of the MS/MS spectra is not acceptable. Th erefore, when one does a search against a database, i.e., Mascot search, false positives (peptide with a low score) can be identifi ed. While this is not of a concern, simply because the human factor can play a role in making a decision, the opposite can happen, as well. For example, a MS/MS with a low Mascot score can lead to identifi cation of a peptide based on a good series of y ions (and sometimes some b ions, as well). However, only inspection of the original raw MS/MS spectrum can confi rm whether it is a good match to the peptide that was identifi ed or not. In addition, the quality of the MS/MS spectra that are acquired in DDA mode depends equally on both the peptides and the type of the instrument. For example, the quadrupole instruments produce MS/MS spectra mostly with y ions, while trap-based instruments produce both b and y ions. Conversely, the same happens the opposite way: false negative identifi cations. While false positive identifi cations are relatively easy to identify, it is very diffi cult and many times almost impossible to identify false negatives. Th erefore, many MS/MS spectra in a proteomics experiments are simply not assigned to any peptide or protein. Some of these MS/MS spectra, although of good quality, do not have any match in any database search, because of unknown PTMs. When they do have a match, these MS/MS spectra can be attributed to substoichiometric modifi cations like phosphorylation or glycosylation (52) . Another problem that is often encountered in MS analysis is redundant MS/MS spectra. Th ese spectra are of good quality, but too many of them correspond to the same peptide, either unmodifi ed or modifi ed with experimental-borne PTMs. Such an example is presented in Fig. 7 . Here, the MS/MS of the precursor ions with m/z of 890.70(3+) and m/z of 896.45(3+) (Fig. 7A-B) are almost identical and lead to the identifi cation of the same peptide: ITAENTPLPIAGVLLPTIPGKLDVNK (Fig. 7C-D) . However, after a closer inspection of the precursor ions shown in Fig. 7A , along with their MS/MS spectra shown in Fig. 8 , we can conclude that in fact, all precursor ions shown in Fig. 7A . Th e fragmentation patterns of these peaks demonstrate that they all correspond to the unmodifi ed and experiment-based modifi ed peptide with the amino acid sequence ITAENTPLPIAGVLLPTIPGKLDVNK.
due to the modifi cation of a lysine residue (either deltahydroxy-allysine (from Lysine) or oxidation of lysine (to aminoadipic acid). Th e same modifi cation is also observed for peak with m/z of 906.11(3+), which derives from peak with m/z of 901.12(3+). A closer look at the precursor peaks from Fig. 7A and their corresponding MS/MS from Fig. 8 indicates that these peaks are related, but all these modifi cations are experimental-borne (deamination, oxidations, etc). Th ese modifi cations, while apparently at a fi rst look are not useful (do not produce any positive identifi cation), may be helpful when full understanding of all modifi cations of a peptide is required (i.e., quality control).
CONCLUSIONS
We have demonstrated that there are many options in identifi cation and characterization of protein PTMs (8, 11, 12, 17, 25, 30, 49, 50, 53) and from a biochemical and proteomic perspective, characterization of common protein PTMs such as phosphorylation or acetylation is straightforward, but it becomes diffi cult when one attempts to identify transient PTMs such as signal transduction pathway-activated phosphorylation or uncommon protein PTMs. For example, there are challenges in identifi cation of transient phosphorylations as well as in identifi cation of PTMs such as nitrosylation, glycosylation, myristoylation, farnesylation, and identifi cation of disulfi de bridges (8, 11, 25, 30, 49, 50, 53) . Furthermore, it is also critical to identify the correct disulfi de linkage in proteins, as a particular connectivity may have one of two diff erent protein confi gurations, with potentially two diff erent activities. Th e simplest example is illustrated by antibodies with identical amino acid sequences, which have similar conformations, but diff erent confi gurations, because their disulfi de linkage is diff erent (54) .
Protein and protein PTMs characterization is always a great challenge, because the PTMs that one expects may not be the same as the ones produced by cells. Th e disulfi de bridges are one example; the glycosylation is another example, as we discovered in our lab (55) , where we demonstrated that introduction of new glycosylation sites in proteins may change the conformation and the location of the glycans on proteins.
Th e greatest challenge that one biochemist could have is in identifi cation and characterization of experimental-borne PTMs. It is known that methionine, cysteine and tryptophan can be oxidized relatively easily. It is also known that hydroxyl-bearing amino acids such as serine, threonine, glutamate and aspartate can easily be dehydrated (water loss) while the amino-bearing amino acids such as arginine, lysine, asparagine and glutamine can easily be deaminated (amino loss). In addition, glutamate and glutamine can also cyclize to pyroglutamate. Furthermore, modifi cations such as alkylation that are expected to target only cysteine, can also modify amino acids other than cysteine and modifi cations such as the HNE, expected to happen at the cysteine and the amino group-bearing amino acids also target other amino acids and therefore, such modifi cations will not be identifi ed by a mass spectrometer (8, 11, 12, 17, 25, 30, 49, 50, 53) .
PERSPECTIVES
Th e human genome is known and from that we came to realize that, genetically, we are not very complicated. We can predict that from the about 30,000 genes that our genome has, about 100,000-300,000 protein isoforms are produced. However, the PTMs like glycosylation, phosphorylation, acetylation, methylation, truncation, etc., the number of proteins, protein isoforms and proteins with one or more PTMs greatly increases the number of diff erent types of proteins that a cell, a tissue, an organ and an organism can produce. To characterize these proteins, we have the MS instrumentation that could accomplish the task of characterization of a whole proteome, however, we neither yet have the software to fully analyze the data produced by these instruments. We also lack the biological expertise to fully understand all PTMs that can occur in a cell at a particular developmental or divisional stage. However, the future of the PTM studies looks bright: PTM-omics.
